RSS

FITX Creative Edge Nutrition Inc.

Last Post: 04/16/26
Followers: 292
Posts Today: 0
Views Today: 15320

FITX Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Oct 29, 2:54 PM EDT
Last0.0000
$ Chg0.0000
Open0.0000
High0.0000
Beta95.7603
Year High0.000
Market Cap4.6K
P/B Ratio—
EPS—
Avg Vol (30d)283.8K
Volume21.5K
% Chg+0.00%
Prev Close0.0000
Low0.0000
VWAP0.00000
Year Low0.000
Total Shares—
Shares Out4.63B
Float4.63B
ExchangeCV EM
Healthcare Pharmaceuticals

FITX Stock Message Board Discussion

Top 10 Most Recent News Articles

Life Time & Dewitt Carolinas Unveil Raleigh's Bold Future

Updated Category News Views 142

Shaping the Skyline with Life Time Living Right in the heart of Midtown Raleigh, they're drawing lines in the sand for what the future of upscale living will look like. On October 29, Dewitt Carolinas and Life Time (NYSE: LTH) officially broke ground on Life Time Living at The Exchange Raleigh. Sure, groundbreaking ceremonies happen all the time, but this one sends a...

Continue Reading
Spire Missouri's Rate Hike: Safety or Financial Squeeze?

Updated Category News Views 120

A Rate Hike Tied to Safety or a Customer Burden? Listen up, what we've got here is Spire Missouri stamping down with a rate hike to bolster safety and reliability. It's a classic gas provider move, asking the Missouri Public Service Commission to greenlight this hike that’d have bills going up—$10 in the west, $13 in the east. That's 11% and 15% jumps. Not small...

Continue Reading
Ascletis Showcases Bold Moves in Obesity Drug Arena

Updated Category News Views 174

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Continue Reading
Ensign Group Faces Class Action Amid Stock Plummet

Updated Category News Views 90

Ensign Group's Recent Troubles Unraveled Let's set the scene: Ensign Group, once riding high at over $170 a share, finds itself knee-deep in allegations that'll make any investor squirm. Now, we're not just talking about a typical market fluctuation here – this is a real smackdown with an 8.2% drop, all thanks to some damning accusations. A Closer Look at Allegations...

Continue Reading
Maritime Launch Takes Flight with TSX Listing

Updated Category News Views 92

Turning Point for Maritime Launch Services It's a new dawn for Maritime Launch Services, folks. They're gearing up to list on the Toronto Stock Exchange (TSX) come November 3, under the ticker "MAXQ." It’s like they're strapping rockets to their business model, and it ain’t just for show. A Strategic Move with High Hopes Listing on the TSX isn’t a mere vanity...

Continue Reading
Amazon and CarbiCrete Innovate with Cement-Free Pavers

Updated Category News Views 88

Amazon Makes a Play for the Planet Look, I'm not one to sprinkle sugar on a cement-related chat, but I gotta say, this CarbiCrete deal has got my attention. Amazon, a titan known for its logistical empire, is diving headfirst into cement-free territory with CarbiCrete's products. In a world where cement production has been a stubborn carbon belcher, there's something big...

Continue Reading
Nevada Organic Phosphate Inches Closer to Major Discovery

Updated Category News Views 93

Another Step Forward at Murdock Mountain In the cutthroat world of mining exploration, hitting that sweet spot between expectation and reality is akin to finding gold. So, when Nevada Organic Phosphate Inc. (CSE: NOP, OTCQB: NOPFF) touts another solid intersection at their Murdock Mountain site, I figure it's worth a closer look. Drill Hole MM26-13, the latest contender,...

Continue Reading
Borr Drilling Faces Prospector 5 Incident Impact

Updated Category News Views 195

Tragedy Strikes Offshore: Borr Drilling's Prospector 5 It's a grim day when maritime operations take a tragic turn. Borr Drilling Limited, listed both on NYSE (NYSE: BORR) and OSE, finds itself in choppy waters following a devastating incident involving the Prospector 5 rig off the coast of Gabon. On November 2, 2026, the company gave an update nobody wants to hear—four...

Continue Reading
Northwind Backs Huge Office-to-Residential Overhaul

Updated Category News Views 159

In the Heart of Midtown: A Major Overhaul I'm telling ya, if there's a piece of news that makes me sit up straight this morning over the breakfast bar, it's this colossal $231 million construction loan announcement by Northwind Group. They're turning 675 Third Avenue, a towering 32-story office behemoth smack in Midtown, into residential apartments. Right here in...

Continue Reading
Kirk Goehring: A Profile in Emerging Banking Leadership

Updated Category News Views 102

A Rising Star in the Banking World You don't see a lot of folks these days making waves in the banking sector quite like Kirk Goehring has. And it's a decent feat, earning a nod from the American Bankers Association (ABA) as one of their 2026 Emerging Leader Awards recipients. For those of you wondering if this is just another hollow accolade, think again. The ABA doesn't...

Continue Reading
iv>

Top 5 Most Recently Viewed Articles

ATYR Stock Investors: Important Class Action Update

Updated Category News Views 139

Key Information for ATYR Pharma Shareholders ATYR Pharma, Inc. has recently faced significant challenges that have caught the attention of its shareholders. Investors who have purchased shares of ATYR during the specified class period are encouraged to stay informed about the ongoing legal developments. Engaging with The Gross Law Firm can provide shareholders with the...

Continue Reading
Zymeworks Stock Target Steady After Positive Trial Results

Updated Category News Views 89

Zymeworks Keeps Stock Rating Steady After ESMO 2024 Results Zymeworks Inc. (NASDAQ: ZYME) has maintained its stock rating and price target after revealing encouraging results from its recent cancer treatment clinical trials at a significant medical conference. The ratings firm H.C. Wainwright has reiterated a Neutral rating and set a price target of $10.00 per share...

Continue Reading
Exploring New Opportunities in Convertible Bonds with BMAX ETF

Updated Category News Views 253

Introduction to the New ETF A recently introduced exchange-traded fund (ETF), known as the REX Bitcoin Corporate Treasury Convertible Bond ETF (BMAX), is gaining attention for its focus on convertible bonds from companies that have Bitcoin included in their financial strategies. This ETF began trading recently and represents a growing trend in the investment landscape....

Continue Reading
iBio Secures Strategic Investments to Propel Biotech Advancements

Updated Category News Views 140

iBio's Strategic Investment Announcement iBio, Inc. (NYSE: IBIO), a pioneer in AI-driven antibody immunotherapies, has made an impactful stride in its mission, announcing the successful closure of a private investment offering totaling over $650,000 from its Board of Directors and corporate officers. This investment is a significant vote of confidence in iBio's strategy...

Continue Reading
Simulmedia Welcomes Jonathan Steuer as Chief Scientist

Updated Category News Views 111

Simulmedia Appoints Jonathan Steuer as Chief Scientist Simulmedia, a leader in cross-channel TV and connected TV (CTV) advertising, is thrilled to announce a significant addition to its executive team. Jonathan Steuer, a prominent figure in media research and data science, has been appointed as the Chief Scientist. With a remarkable background as a scientist and...

Continue Reading